SanaCurrents Archives | Page 2 of 33 | GeoInvesting

April 29, 2023

SanaCurrents on Verrica’s (VRCA) drug-device combo to become the first treatment for benign skin disease in children

This content is for members only

April 22, 2023

SanaCurrents on Viridian’s (VRDN) rising challenger in thyroid eye disease (TED)

This content is for members only

April 15, 2023

SanaCurrents on ImmunoGen’s (IMGN) Elahere confirmatory trial in platinum-resistant ovarian cancer

This content is for members only

April 3, 2023

SanaCurrents on PTC Therapeutics’ (PTCT) entry into the rare disease Friedreich’s ataxia market

This content is for members only

March 25, 2023

SanaCurrents on FDA decision for IVERIC’s (ISEE) fast follower to treat a leading cause of blindness

This content is for members only

March 18, 2023

SanaCurrents on Scholar Rock’s (SRRK) improving treatment for spinal muscular atrophy (SMA)

This content is for members only

March 11, 2023

SanaCurrents on Wave Life Sciences’ (WVE) precision approach to treating Amyotrophic lateral sclerosis (ALS)

This content is for members only

March 4, 2023

SanaCurrents on PDUFA decision for SpringWorks (SWTX) first drug to treat desmoid tumors

This content is for members only